Company Overview of NeuroTherapeutics Pharma, Inc.
NeuroTherapeutics Pharma, Inc. develops and markets therapeutics for patients suffering from central nervous system (CNC) disorders. The company focuses on developing a pipeline of compounds and medicines for the treatment of neuropathic pain, inflammatory pain, acute pain, epilepsy, anxiety, autism, migraine, schizophrenia, and bipolar. Its lead product NTP-2014 is a molecule compound that has applications in various diseases, including epilepsy, pain, and other CNS indications. The company was incorporated in 2006 and is based in Chicago, Illinois.
8750 West Bryn Mawr Avenue
Chicago, IL 60631
Founded in 2006
Key Executives for NeuroTherapeutics Pharma, Inc.
NeuroTherapeutics Pharma, Inc. does not have any Key Executives recorded.
Similar Private Companies By Industry
|Janssen Products, LP||United States|
|Evergreen Licensing||United States|
|Bexion Pharmaceuticals, LLC||United States|
|Syndexa Pharmaceuticals Corporation||United States|
|Ascio Pharmaceuticals, Inc.||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
To contact NeuroTherapeutics Pharma, Inc., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.